250 μg or 500 μg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study

Paul O’Connor, Timon Bogumil, Maria Groth et al.|The Lancet Neurology|2009

Cited by 403